Free Trial
CVE:RGD

Reunion Gold (RGD) Stock Price, News & Analysis

Reunion Gold logo
C$0.73 0.00 (0.00%)
As of 07/16/2024

About Reunion Gold Stock (CVE:RGD)

Key Stats

Today's Range
C$0.73
C$0.76
50-Day Range
C$0.73
C$0.73
52-Week Range
C$0.32
C$0.76
Volume
834,200 shs
Average Volume
896,874 shs
Market Capitalization
C$914.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$0.72
Consensus Rating
N/A

Company Overview

Receive RGD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reunion Gold and its competitors with MarketBeat's FREE daily newsletter.

RGD Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

RGD Stock Analysis - Frequently Asked Questions

Reunion Gold's stock was trading at C$0.73 at the beginning of 2025. Since then, RGD shares have increased by 0.0% and is now trading at C$0.73.

Shares of RGD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Reunion Gold investors own include Royal Gold (RGLD), Avino Silver & Gold Mines (ASM), Concepta PLC (CPT.L) (CPT), Clarus Therapeutics (CRXTQ), Citius Pharmaceuticals (CTXR), VanEck Junior Gold Miners ETF (GDXJ) and

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Gold
Sub-Industry
N/A
Current Symbol
CVE:RGD
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$0.72
High Stock Price Target
C$0.72
Low Stock Price Target
C$0.72
Potential Upside/Downside
-1.4%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$61.42 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.09 per share
Price / Cash Flow
7.79
Book Value
C$0.05 per share
Price / Book
15.96

Miscellaneous

Outstanding Shares
1,252,228,514
Free Float
N/A
Market Cap
C$914.13 million
Optionable
Not Optionable
Beta
1.21
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (CVE:RGD) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners